Alkem Laboratories Share Price

NSE: ALKEM

₹ 5,602.00

+₹17.00 (0.30%)

Last updated 23 Jul, 2026, 15:41 IST

Alkem Laboratories Share Price Today

As of 23 Jul 2026, Alkem Laboratories share price is ₹5,602.00. The stock opened at ₹5,601.00, compared to its previous close of ₹5,585.00. During today's trading session, Alkem Laboratories share price moved in the range of ₹5,511.50 to ₹5,637.00, with an average price of ₹5,574.25 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,738.50 and a high of ₹5,933.50. On the performance front, Alkem Laboratories share price has declined by 2.58% over the last six months and is up 12.60% on a year-on-year basis.

₹5,511.50

0.30% up today

₹5,637.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 13.61% YoY

Latest Earning

Net Profit TrendUp by 6.19% YoY

Latest Earning

Revenue TrendUp by 13.65% YoY

Stock Performance

OutperformingBeat Nifty by 5.51 % in last 1 month

Shareholding Pattern

PromoterPromoter decreased stake by 2.92%

Shareholding Pattern

DIIDII increased stake by 1.66%

Shareholding Pattern

FIIFII increased stake by 2.56%

Alkem Laboratories Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹5,58,870+₹58,870 (+11.77%)

3 Year

₹7,03,990+₹2,03,990 (+40.80%)

5 Year

₹8,11,038+₹3,11,038 (+62.21%)

₹5,026.50₹6,143.50

Circuit Low

Circuit High

₹4,738.50₹5,933.50

52-Week Low

52-Week High

Circuit

₹5,026.50

₹6,143.50

52-week

₹4,738.50

₹5,933.50

Mkt Cap Cr

66,821.90

P/E

28.42

P/B

4.84

ROE

16.66%

D/E

0.04

ROCE

18.61%

Div. Yield

0.95%

EPS(TTM)

182.76

Turnover

0.67

EV/EBITDA

19.99

Net Margin

0.00%

Op. Margin

0.00%

ROA

11.27%

Quick Ratio

0.00

Curr. Ratio

3.57

Mkt Cap Cr

66,821.90

P/E

28.42

P/B

4.84

ROE

16.66%

D/E

0.04

ROCE

18.61%

Div. Yield

0.95%

EPS(TTM)

182.76

Turnover

0.67

EV/EBITDA

19.99

Net Margin

0.00%

Op. Margin

0.00%

ROA

11.27%

Quick Ratio

0.00

Curr. Ratio

3.57

Based on fundamentals, this stock's

Performance

Excellent

Alkem Lab outperforming all market indices

Valuation

Expensive

Alkem Lab PE is significantly higher than its peers

Earnings

Neutral

Alkem Lab earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,66,179.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,96,095.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,91,530.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,14,318.00	25.47	2.87	11.79%	0.00	15.66%	2.89	1.06%	0.49	43.52
Lupin	1,10,001.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Zydus Lifesciences	1,12,693.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Mankind Pharma	1,05,068.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	98,742.10	31.02	2.59	11.07%	0.18	12.54%	377.96	0.68%	0.47	38.68
Aurobindo Pharma	89,034.00	25.42	2.35	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	85,232.50	60.26	10.10	18.21%	0.45	16.70%	10.19	0.20%	0.97	13.72

Alkem Laboratories Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹12,964.52	₹12,667.58	₹11,599.26	₹10,634.19
Other Income	₹493.74	₹310.84	₹216.08	₹162.65
Total Revenue	₹13,458.26	₹12,978.42	₹11,815.34	₹10,796.84
Total Expenses	₹10,931.23	₹10,833.80	₹10,407.59	₹8,937.60
Profit Before Tax	₹2,527.03	₹2,023.13	₹1,304.77	₹1,844.28
Tax	₹311.03	₹211.67	₹297.96	₹163.96
Profit After Tax	₹2,216.00	₹1,811.46	₹1,006.81	₹1,680.32
EPS - Basic	₹181.11	₹150.19	₹82.31	₹137.63
EPS - Diluted	₹181.11	₹150.19	₹82.31	₹137.63

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹2,527.03	₹2,023.13	₹1,304.77	₹1,844.28
Income before WC changes	₹2,630.83	₹2,406.70	₹1,629.12	₹2,052.88
Change in Assets	-₹454.79	-₹430.50	₹261.69	-₹938.47
Change in Liabilities	₹240.82	₹378.81	₹65.08	₹393.51
Change in WC	-₹213.97	-₹51.69	₹326.77	-₹544.96
Cash flow from Operations	₹1,912.84	₹1,948.07	₹1,682.50	₹1,111.02
Cash flow from Investing	-₹1,298.76	-₹1,008.50	₹112.84	-₹1,435.13
Cash flow from Financing	-₹810.99	-₹1,145.01	-₹1,760.82	₹379.57
Total Cash Flow	-₹196.91	-₹205.44	₹34.52	₹55.46
Cash (Start of the year)	₹66.31	₹273.80	₹232.18	₹174.22
Cash (End of the year)	-₹120.09	₹66.31	₹273.80	₹232.18

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹6,879.91	₹5,163.32	₹5,026.95	₹5,635.49
Current Assets	₹10,811.19	₹10,411.58	₹8,729.70	₹8,433.70
Total Assets	₹17,691.10	₹15,574.90	₹13,756.65	₹14,069.19
Current Liabilities	₹3,958.69	₹3,994.55	₹3,707.15	₹4,805.34
Net Current Asset	₹6,852.50	₹6,417.03	₹5,022.55	₹3,628.36
Non-Current Liabilities	₹1,298.78	₹865.95	₹614.50	₹416.52
Equity Capital	₹12,433.63	₹10,714.40	₹9,435.00	₹8,847.33
Total Equity & Liabilities	₹17,691.10	₹15,574.90	₹13,756.65	₹14,069.19

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹8,813.44	₹7,963.85	₹9,054.55	₹8,829.81
Other Income	₹507.06	₹305.99	₹266.29	₹199.89
Total Revenue	₹9,320.50	₹8,269.84	₹9,320.84	₹9,029.70
Total Expenses	₹7,016.96	₹6,611.88	₹7,993.85	₹7,276.33
Profit Before Tax	₹2,303.54	₹1,594.13	₹1,326.99	₹1,753.37
Tax	₹213.82	₹33.62	₹192.52	₹212.12
Profit After Tax	₹2,089.72	₹1,560.51	₹1,134.47	₹1,541.25
EPS - Basic	₹190.77	₹146.13	₹94.88	₹128.90
EPS - Diluted	₹190.77	₹146.13	₹94.88	₹128.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹2,597.39	₹1,881.03	₹1,326.99	₹1,753.37
Income before WC changes	₹2,546.05	₹2,092.77	₹1,455.88	₹1,861.36
Change in Assets	-₹179.20	-₹238.27	₹169.14	-₹594.55
Change in Liabilities	₹219.19	₹184.89	₹36.56	₹367.38
Change in WC	₹39.99	-₹53.38	₹205.70	-₹227.17
Cash flow from Operations	₹2,189.41	₹1,686.56	₹1,437.42	₹1,299.34
Cash flow from Investing	-₹1,007.41	-₹865.60	₹197.04	-₹1,669.33
Cash flow from Financing	-₹1,036.89	-₹959.04	-₹1,711.27	₹436.59
Total Cash Flow	₹145.11	-₹138.08	-₹76.81	₹66.60
Cash (Start of the year)	-₹133.07	₹5.01	₹81.82	₹15.22
Cash (End of the year)	₹12.04	-₹133.07	₹5.01	₹81.82

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹8,241.60	₹5,997.72	₹5,959.01	₹6,308.56
Current Assets	₹7,354.00	₹8,040.08	₹6,772.21	₹6,860.61
Total Assets	₹15,595.60	₹14,037.80	₹12,731.22	₹13,169.17
Current Liabilities	₹2,543.44	₹3,106.40	₹3,044.83	₹4,123.76
Net Current Asset	₹4,810.56	₹4,933.68	₹3,727.38	₹2,736.85
Non-Current Liabilities	₹730.33	₹376.79	₹336.54	₹301.75
Equity Capital	₹12,321.83	₹10,554.61	₹9,349.85	₹8,743.66
Total Equity & Liabilities	₹15,595.60	₹14,037.80	₹12,731.22	₹13,169.17

* All values are in INR Crore

Qty

Bid

5602

Ask

Qty

Bid Total: 8

Ask Total: 0

Buy orders: 100%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

52.13

Neutral

ATR (14)

127.39

Neutral

STOCH(9,6)

35.27

Neutral

STOCH RSI (14)

Bullish

ADX(9)

29.1

Bearish

UO(9)

50.43

Neutral

ROC(12)

-0.24

Bearish

WillR(14)

-62.32

Neutral

Period

Simple value

Exponential vaue

5638.4

5627.75

10D

5633.75

5620.05

20D

5584

5578.43

50D

5464.72

5508.56

100D

5451.81

5500.37

About Alkem Laboratories

ISIN

INE540L01014

Sector Market Cap

₹ 66,821.9 Cr

Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.

Alkem Laboratories Financial Highlights

Revenue: Alkem Laboratories reported revenue of ₹15,295.62 crore in FY26 vs ₹13,458.26 crore in FY25. It showed an increase of 13.65% on a yearly basis.
Operating Profit: Alkem Laboratories reported an operating profit of ₹2,870.89 crore in FY26 vs ₹2,527.03 crore in FY25. It showed an increase of 13.61% on a year-on-year basis.
Net Profit: Alkem Laboratories reported a net profit of ₹2,353.13 crore in FY26 vs ₹2,216.00 crore in FY25. It showed an increase of 6.19% on a yearly basis.

Alkem Laboratories Quarterly Result Highlights

Alkem Laboratories reported revenue of ₹3,803.39 crore in Mar 2026, compared with ₹3,879.92 crore in Dec 2025, representing a decrease of 1.97% on a quarter-on-quarter (QoQ) basis.
Alkem Laboratories reported an operating profit of ₹422.85 crore in Mar 2026, compared with ₹781.20 crore in Dec 2025, representing a decrease of 45.87% on a quarter-on-quarter (QoQ) basis.
Alkem Laboratories reported a profit of ₹251.68 crore in Mar 2026, compared with ₹653.53 crore in Dec 2025, reflecting a decrease of 61.49% on a QoQ basis.
The earnings per share (EPS) of Alkem Laboratories stood at ₹181.11 during Mar 2026.